Literature DB >> 21870828

Actinopolysporins A-C and tubercidin as a Pdcd4 stabilizer from the halophilic actinomycete Actinopolyspora erythraea YIM 90600.

Li-Xing Zhao1, Sheng-Xiong Huang, Shu-Kun Tang, Cheng-Lin Jiang, Yanwen Duan, John A Beutler, Curtis J Henrich, James B McMahon, Tobias Schmid, Johanna S Blees, Nancy H Colburn, Scott R Rajski, Ben Shen.   

Abstract

Our current natural product program utilizes new actinomycetes originating from unexplored and underexplored ecological niches, employing cytotoxicity against a selected panel of cancer cell lines as the preliminary screen to identify hit strains for natural product dereplication, followed by mechanism-based assays of the purified natural products to discover potential anticancer drug leads. Three new linear polyketides, actinopolysporins A (1), B (2), and C (3), along with the known antineoplastic antibiotic tubercidin (4), were isolated from the halophilic actinomycete Actinopolyspora erythraea YIM 90600, and the structures of the new compounds were elucidated on the basis of spectroscopic data interpretation. All four compounds were assayed for their ability to stabilize the tumor suppressor programmed cell death protein 4 (Pdcd4), which is known to antagonize critical events in oncogenic pathways. Only 4 significantly inhibited proteasomal degradation of a model Pdcd4-luciferase fusion protein, with an IC50 of 0.88±0.09 μM, unveiling a novel biological activity for this well-studied natural product.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21870828      PMCID: PMC3179765          DOI: 10.1021/np200603g

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  20 in total

Review 1.  Thermophilic and halophilic extremophiles.

Authors:  M T Madigan; A Oren
Journal:  Curr Opin Microbiol       Date:  1999-06       Impact factor: 7.934

2.  Actinopolyspora alba sp. nov. and Actinopolyspora erythraea sp. nov., isolated from a salt field, and reclassification of Actinopolyspora iraqiensis Ruan et al. 1994 as a heterotypic synonym of Saccharomonospora halophila.

Authors:  Shu-Kun Tang; Yun Wang; Hans-Peter Klenk; Rong Shi; Kai Lou; Yun-Jiao Zhang; Chao Chen; Ji-Sheng Ruan; Wen-Jun Li
Journal:  Int J Syst Evol Microbiol       Date:  2010-08-20       Impact factor: 2.747

Review 3.  Microbial genomics for the improvement of natural product discovery.

Authors:  Steven G Van Lanen; Ben Shen
Journal:  Curr Opin Microbiol       Date:  2006-05-02       Impact factor: 7.934

4.  Structural basis for inhibition of translation by the tumor suppressor Pdcd4.

Authors:  Nicole LaRonde-LeBlanc; Arti N Santhanam; Alyson R Baker; Alexander Wlodawer; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

5.  S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth.

Authors:  N Valerio Dorrello; Angelo Peschiaroli; Daniele Guardavaccaro; Nancy H Colburn; Nicholas E Sherman; Michele Pagano
Journal:  Science       Date:  2006-10-20       Impact factor: 47.728

6.  The biosynthesis of the 7-deazaadenine ribonucleoside, tubercidin, by Streptomyces tubercidicus.

Authors:  M E Smulson; R J Suhadolnik
Journal:  J Biol Chem       Date:  1967-06-25       Impact factor: 5.157

7.  Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion.

Authors:  Hsin-Sheng Yang; Connie P Matthews; Timothy Clair; Qing Wang; Alyson R Baker; Chou-Chi H Li; Tse-Hua Tan; Nancy H Colburn
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

8.  Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.

Authors:  Aaron P Jansen; Corinne E Camalier; Nancy H Colburn
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

9.  Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors.

Authors:  J H Leupold; H-S Yang; N H Colburn; I Asangani; S Post; H Allgayer
Journal:  Oncogene       Date:  2007-02-12       Impact factor: 9.867

Review 10.  Advances in polyketide synthase structure and function.

Authors:  Steven G Van Lanen; Ben Shen
Journal:  Curr Opin Drug Discov Devel       Date:  2008-03
View more
  16 in total

Review 1.  Leveraging ecological theory to guide natural product discovery.

Authors:  Michael J Smanski; Daniel C Schlatter; Linda L Kinkel
Journal:  J Ind Microbiol Biotechnol       Date:  2015-10-05       Impact factor: 3.346

2.  New isofuranonaphthoquinones and isoindolequinones from Streptomyces sp. CB01883.

Authors:  Zhikai Guo; Guohui Pan; Zhengren Xu; Dong Yang; Xiangcheng Zhu; Yong Huang; Li-Xing Zhao; Yi Jiang; Yanwen Duan; Ben Shen
Journal:  J Antibiot (Tokyo)       Date:  2016-10-12       Impact factor: 2.649

3.  Cryptocaryol Structure-Activity Relationship Study of Cancer Cell Cytotoxicity and Ability to Stabilize PDCD4.

Authors:  Michael F Cuccarese; Yanping Wang; Penny J Beuning; George A O'Doherty
Journal:  ACS Med Chem Lett       Date:  2014-02-17       Impact factor: 4.345

4.  Neaumycin: a new macrolide from Streptomyces sp. NEAU-x211.

Authors:  Sheng-Xiong Huang; Xiang-Jing Wang; Yijun Yan; Ji-Dong Wang; Ji Zhang; Chong-Xi Liu; Wen-Sheng Xiang; Ben Shen
Journal:  Org Lett       Date:  2012-02-14       Impact factor: 6.005

5.  Angucyclines and Angucyclinones from Streptomyces sp. CB01913 Featuring C-Ring Cleavage and Expansion.

Authors:  Ming Ma; Mostafa E Rateb; Qihui Teng; Dong Yang; Jeffrey D Rudolf; Xiangcheng Zhu; Yong Huang; Li-Xing Zhao; Yi Jiang; Xiuling Li; Christoph Rader; Yanwen Duan; Ben Shen
Journal:  J Nat Prod       Date:  2015-09-03       Impact factor: 4.050

6.  Identification of antifungal natural products via Saccharomyces cerevisiae bioassay: insights into macrotetrolide drug spectrum, potency and mode of action.

Authors:  Brad Tebbets; Zhiguo Yu; Douglas Stewart; Li-Xing Zhao; Yi Jiang; Li-Hua Xu; David Andes; Ben Shen; Bruce Klein
Journal:  Med Mycol       Date:  2012-08-28       Impact factor: 4.076

7.  Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor.

Authors:  Magdalena M Bajer; Michael M Kunze; Johanna S Blees; Heidi R Bokesch; Hanyong Chen; Thilo F Brauss; Zigang Dong; Kirk R Gustafson; Ricardo M Biondi; Curtis J Henrich; James B McMahon; Nancy H Colburn; Tobias Schmid; Bernhard Brüne
Journal:  Biochem Pharmacol       Date:  2014-02-07       Impact factor: 5.858

8.  Systematic and biotechnological aspects of halophilic and halotolerant actinomycetes.

Authors:  Javad Hamedi; Fatemeh Mohammadipanah; Antonio Ventosa
Journal:  Extremophiles       Date:  2012-11-06       Impact factor: 2.395

9.  Erioflorin stabilizes the tumor suppressor Pdcd4 by inhibiting its interaction with the E3-ligase β-TrCP1.

Authors:  Johanna S Blees; Heidi R Bokesch; Daniela Rübsamen; Kathrin Schulz; Larissa Milke; Magdalena M Bajer; Kirk R Gustafson; Curtis J Henrich; James B McMahon; Nancy H Colburn; Tobias Schmid; Bernhard Brüne
Journal:  PLoS One       Date:  2012-10-02       Impact factor: 3.240

10.  Biosynthetic potential-based strain prioritization for natural product discovery: a showcase for diterpenoid-producing actinomycetes.

Authors:  Pengfei Xie; Ming Ma; Mostafa E Rateb; Khaled A Shaaban; Zhiguo Yu; Sheng-Xiong Huang; Li-Xing Zhao; Xiangcheng Zhu; Yijun Yan; Ryan M Peterson; Jeremy R Lohman; Dong Yang; Min Yin; Jeffrey D Rudolf; Yi Jiang; Yanwen Duan; Ben Shen
Journal:  J Nat Prod       Date:  2014-01-31       Impact factor: 4.050

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.